主动脉瓣狭窄合并冠心病的治疗管理
本综述探讨严重主动脉瓣狭窄(AS)合并冠心病(CAD)患者的最佳管理策略。传统上采用外科主动脉瓣置换(SAVR)联合冠状动脉旁路移植术,但经导管主动脉瓣植入(TAVI)的证据不断增加,使完全经皮治疗成为可能。综述分析了侵入性冠状动脉造影的诊断价值、功能性评估的局限性以及血运重建的适应证,强调心脏团队在个体化决策中的核心作用。
要点
- 侵入性冠状动脉造影是AS患者术前评估CAD的核心手段。
- TAVI术前对无或轻微心绞痛患者常规血运重建所有显著CAD缺乏证据支持。
- 心脏团队对临床、解剖和操作因素的综合评估是决策关键。
核心结论
- TAVI为严重AS合并CAD患者提供了完全经皮治疗的潜力。
- TAVI术前对轻微心绞痛患者常规血运重建所有显著CAD不被最新证据支持。
- 心脏团队在复杂患者个体化决策中仍不可或缺。
研究设计与样本
- 综述,总结严重AS合并CAD患者管理相关证据。
主要发现
- AS与CAD因共享病理生理过程而频繁共存。
- TAVI证据增加使其成为跨手术风险谱严重AS的替代治疗。
- AS背景下冠状动脉狭窄功能性评估的获益尚未完全确立。
- SAVR患者显著近端CAD血运重建指征近期未变。
临床怎么用
- 对拟行SAVR或TAVI的AS患者用侵入性冠状动脉造影检测CAD。
- TAVI术前对轻微心绞痛患者不常规血运重建所有显著CAD。
- 考虑血运重建时综合评估临床、解剖和操作因素以个体化决策。
局限性
- AS背景下功能性评估冠状动脉狭窄的获益尚未完全确立。
- 需等待正在进行的试验提供TAVI受者生理学指导血运重建的新见解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aortic stenosis (AS) is the most common valvular heart disorder in the elderly population. As a result of the shared pathophysiological processes, AS frequently coexists with coronary artery disease (CAD). These patients have traditionally been managed through surgical aortic valve replacement (SAVR) and coronary artery bypass grafting. However, increasing body of evidence supports transcatheter aortic valve implantation (TAVI) as an alternative treatment for severe AS across the spectrum of operative risk. This has created the potential for treating AS and concurrent CAD completely percutaneously. In this review we consider the evidence guiding the optimal management of patients with severe AS and CAD. While invasive coronary angiography plays a central role in detecting CAD in patients with AS undergoing surgery or TAVI, the benefits of complementary functional assessment of coronary stenosis in the context of AS have not been fully established. Although the indications for revascularisation of significant proximal CAD in SAVR patients have not recently changed, routine revascularisation of all significant CAD before TAVI in patients with minimal angina is not supported by the latest evidence. Several ongoing trials will provide new insights into physiology-guided revascularisation in TAVI recipients. The role of the heart team remains essential in this complex patient group, and if revascularisation is being considered careful evaluation of clinical, anatomical and procedural factors is essential for individualised decision-making.
引用
- Androshchuk V, Patterson T, Redwood SR, et al. Management of coronary artery disease in patients with aortic stenosis. Heart. 2023. PMID: 36526337. doi:10.1136/heartjnl-2022-321605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。